Huabei pharmaceutical's patent for two tip antitumor compounds will be approved soon

A patent applied for by Huabei Pharmaceutical Group new drug research and Development Co., Ltd., a subsidiary of Huabei pharmaceutical, with a shareholding of 97%, is recently authorized by the State Intellectual Property Office The company will keep the announcement expectation after obtaining the patent certificate According to the introduction, the invention relates to a kind of compound obtained from the two tips of traditional Chinese medicine, a preparation method and a use thereof, and relates to the use of the compound for the preparation of anti-cancer drugs, especially for the treatment of leukaemia combined with lung cancer, colon cancer, liver cancer, sarcoma and other cancers About the two tips: the two tips are the aliases of Anemone raddeana Regel and Aconitum flavum hand - Mazz, which can be used for medicine Anemone is a perennial herb distributed in Northeast Shandong, Liaoning, Jilin and Heilongjiang in China It is in the forest or in the shade of grassland at an altitude of 800 meters Rhizome can be used as medicine to treat rheumatic lumbocrural pain, arthritis, furuncle, carbuncle and other diseases It is a perennial herb, distributed in Northwest Sichuan, North Tibet, Qinghai, Gansu, South Ningxia and South Inner Mongolia It grows at an altitude of 2000-3700 meters under grass slope or sparse forest Tuberous roots are highly toxic, used for medicinal purposes, for the treatment of injuries caused by falls, rheumatism and arthralgia